Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Dec;50(6):847–851. doi: 10.1038/bjc.1984.267

Interaction of diethylaminoreserpine with cells of a transplantable tumour in vivo.

S Lehnert
PMCID: PMC1976995  PMID: 6498082

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hill R. P., Ng R., Warren B. F., Bush R. S. The effect of intercellular contact on the radiation sensitivity of KHT sarcoma cells. Radiat Res. 1979 Jan;77(1):182–192. [PubMed] [Google Scholar]
  2. Kallman R. F., Silini G., Van Putten L. M. Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. J Natl Cancer Inst. 1967 Sep;39(3):539–549. [PubMed] [Google Scholar]
  3. Lehnert S., Fisher G., Methot G. Radioprotection of normal and malignant tissue in the mouse by diethylaminoreserpine. Int J Radiat Biol Relat Stud Phys Chem Med. 1981 Jul;40(1):63–73. [PubMed] [Google Scholar]
  4. Lehnert S. Toxicity of diethylaminoreserpine to a transplantable tumor: the significance of the presence of hypoxic cells. Cancer Res. 1982 Aug;42(8):3028–3032. [PubMed] [Google Scholar]
  5. Lehnert S. Toxicity to tumour cells of diethylaminoreserpine. Br J Cancer Suppl. 1980 Apr;4:222–225. [PMC free article] [PubMed] [Google Scholar]
  6. Stitzel R. E. The biological fate of reserpine. Pharmacol Rev. 1976 Sep;28(3):179–208. [PubMed] [Google Scholar]
  7. Thomson J. E., Rauth A. M. An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiat Res. 1974 May;58(2):262–276. [PubMed] [Google Scholar]
  8. Van Putten L. M., Kallman R. F. Oxygenation status of a transplantable tumor during fractionated radiation therapy. J Natl Cancer Inst. 1968 Mar;40(3):441–451. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES